JPMorgan Chase & Co’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Sell |
|
|||||
|
2025
Q1 | $158K | Buy |
|
|||||
|
2024
Q4 | $246K | Buy |
|
|||||
|
2024
Q3 | $270K | Buy |
|
|||||
|
2024
Q2 | $230K | Sell |
|
|||||
|
2024
Q1 | $1.61M | Buy |
|
|||||
|
2023
Q4 | $319K | Buy |
|
|||||
|
2023
Q3 | $3.8K | Hold |
|
|||||
|
2023
Q2 | $2.53K | Hold |
|
|||||
|
2023
Q1 | $2K | Hold |
|
|||||
|
2022
Q4 | $1K | Hold |
|
|||||
|
2022
Q3 | $1K | Hold |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $130K | Sell |
|
|||||
|
2021
Q4 | $579K | Sell |
|
|||||
|
2021
Q3 | $1.04M | Sell |
|
|||||
|
2021
Q2 | $1.19M | Sell |
|
|||||
|
2021
Q1 | $2.92M | Sell |
|
|||||
|
2020
Q4 | $7.28M | Buy |
|
|||||
|
2020
Q3 | $9.04M | Sell |
|
|||||
|
2020
Q2 | $5.12M | Buy |
|
|||||
|
2020
Q1 | $2.59M | Buy |
|
|||||
|
2019
Q4 | $99K | Buy |
|
|||||
|
2019
Q3 | $113K | Sell |
|
|||||
|
2019
Q2 | $1.18M | Sell |
|
|||||
|
2019
Q1 | $1.67M | Sell |
|
|||||
|
2018
Q4 | $2.3M | Buy |
|
|||||
|
2018
Q3 | $542K | Buy |
|
|||||
|
2018
Q2 | $51K | Sell |
|
|||||
|
2018
Q1 | $51K | Sell |
|
|||||
|
2017
Q4 | $396K | Buy |
|
|||||
|
2017
Q3 | $345K | Buy |
|
|||||
|
2017
Q2 | $2K | Sell |
|
|||||
|
2017
Q1 | $107K | Buy |
|
|||||
|
2016
Q4 | $2K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $31K | Buy |
|
|||||
|
2016
Q1 | $17K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $16.2M | Sell |
|
|||||
|
2015
Q2 | $71M | Buy |
|
|||||
|
2015
Q1 | $113M | Sell |
|
|||||
|
2014
Q4 | $98.9M | Buy |
|
|||||
|
2014
Q3 | $61.7M | Buy |
|
|||||
|
2014
Q2 | $73.7M | Buy |
|
|||||
|
2014
Q1 | $57.6M | Sell |
|
|||||
|
2013
Q4 | $55.7M | Sell |
|
|||||
|
2013
Q3 | $36.6M | Buy |
|
|||||
|
2013
Q2 | $26.3M | Buy |
|